Showing 101 - 110 of 128 posts
https://www.coltonconsortium.org/publications/quadriparesis-and-paraparesis-following-chimeric-antigen-receptor-t-cell-therapy-in-children-and-adolescents/
https://www.coltonconsortium.org/publications/differences-in-disease-characteristics-and-treatment-exposures-between-paediatric-and-adult-onset-inflammatory-bowel-disease-using-a-registry-based-cohort/
https://www.coltonconsortium.org/publications/effect-of-bimekizumab-on-patient-reported-disease-impact-in-patients-with-psoriatic-arthritis-1-year-results-from-two-phase-3-studies/
https://www.coltonconsortium.org/publications/efficacy-and-safety-of-avacopan-in-patients-aged-65-years-and-older-with-anca-associated-vasculitis-a-post-hoc-analysis-of-data-from-the-advocate-trial/
https://www.coltonconsortium.org/publications/egfr-stat1-pathway-drives-fibrosis-initiation-in-fibroinflammatory-skin-diseases/
https://www.coltonconsortium.org/publications/expert-perspective-diagnosis-and-treatment-of-castleman-disease/
https://www.coltonconsortium.org/publications/extrarenal-symptoms-associate-with-worse-quality-of-life-in-patients-enrolled-in-the-amp-ra-sle-lupus-nephritis-network/
https://www.coltonconsortium.org/publications/ifn-%ce%b3-producing-th1-cells-and-dysfunctional-regulatory-t-cells-contribute-to-the-pathogenesis-of-sjogrens-disease/
https://www.coltonconsortium.org/publications/crizanlizumab-for-retinal-vasculopathy-with-cerebral-leukoencephalopathy-in-a-phase-ii-clinical-study/
https://www.coltonconsortium.org/publications/decoding-immunobiology-through-genetic-errors-of-immunity/
